Across TCGA pan-cancer cohorts, DAAM1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated DAAM1 data layer compared with 22 for mass-spec protein and 4 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher DAAM1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated DAAM1 expression acts as an unfavorable survival marker, although some lineages such as COAD and HNSC show a favorable association.
COAD, LUAD, and HNSC are the cancer types where DAAM1 mass-spec protein most reproducibly stratifies survival.